J&J vaccine on pause over blood clot concerns
FOX News correspondent Jonathan Serrie joins ‘Special Report’ with the details from Atlanta
The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential “adverse side effects” from the vaccine.
Virginia State Vaccination Coordinator Danny Avula released a statement on Tuesday that confirmed the March death is being investigated by the Centers for Disease Control and Prevention over a potential link to the vaccine.
The Virginia death was reported to the CDC’s Vaccine Adverse Event Reporting System, Avula said.
Johnson & Johnson said on Tuesday that it would delay the rollout of its shot in Europe until the probe in the U.S. was ironed out.
WHITE HOUSE DIDN’T GET A HEADS UP ON JOHNSON & JOHNSON VACCINE HALT, ZIENTS SAYS
Federal health agencies on Tuesday called for a pause on administering the Johnson & Johnson vaccine to dig deeper into reports from six women between the ages of 18 and 48 who said they fell ill with a “a rare and severe type of blood clot” – as described by the CDC – within two weeks of receiving the vaccine. Only one woman has died so far.
CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE
Nearly 7 million doses of the vaccine have been administered in the U.S.
The CDC is set to convene a meeting on Wednesday to review the cases.
The pause is expected to be lifted in the near-future.
In a statement, Johnson & Johnson acknowledged that the health and safety of people who use its products is its number one priority.
Source: Read Full Article